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causative effects has the potential to provide new insights into the 
etiology of reproductive diseases and novel diagnostic and clinical 
technologies for infertility treatment.
RESULTS
We report a large meta-analysis of genome-wide association studies 
(GWAS) of 251,151 individuals for AFB and 343,072 individuals for 
NEB from a total of 62 cohorts of European ancestry. We identify 
12 independent loci (10 of which are new and 2 of which were previ-
ously identified in a study on age at first sexual intercourse11) that are 
significantly associated with AFB and/or NEB in men, women or both 
sexes combined (Table 1). Follow-up analyses identified a number of 
genetic variants and genes that likely drive the GWAS associations. 
We also quantified the genetic overlap with biologically adjacent 
reproductive, developmental, neuropsychiatric and behavioral 
phenotypes. A detailed description of all materials and methods is 
available in the Supplementary Note.
Meta-analysis	of	GWAS
Associations of AFB (mean ± s.d., 26.8 ± 4.78 years) and/or NEB 
(mean ± s.d., 2.3 ± 1.43 children) with SNPs imputed from NCBI Build 
37 HapMap phase 2 data were examined in 62 cohorts using multi-
ple linear regression under an additive model, in men and women 
separately (Supplementary Note). Associations were adjusted for 
principal components, to reduce confounding by population strati-
fication15, as well as for the birth year of the respondent and its square 
and cube to control for nonlinear birth cohort effects (Supplementary 
Tables 1 and 2, and Supplementary Note). NEB was assessed only for 
those who had completed their reproductive period (age ≥45 years for 
women and ≥55 years for men), while AFB was only assessed for those 
who were parous. Quality control was conducted in two independent 
centers using QCGWAS16 and EasyQC17 (Supplementary Note). 
Results were subsequently submitted to meta-analysis for the 2.4 million 
SNPs that passed quality control filters (Supplementary Note) and 
are reported for men and women combined and separately.
Human reproductive behavior—AFB and NEB—has been associated 
with human development1,2, infertility3,4 and neuropsychiatric 
disorders5. Reproductive tempo (AFB) and quantum (NEB) are 
cross-cutting topics in the medical, biological, evolutionary and 
social sciences and are central in national and international policies6. 
Advanced societies have experienced a rapid postponement of AFB, 
with the mean AFB of women now being 28–29 years in many 
countries7. This increase in AFB has been linked to lower fertility 
rates, unprecedented rates of childlessness (~20%) and infertility, 
which affects 10 to 15% of couples8. An estimated 48.5 million couples 
worldwide are infertile, with a large part of subfertility, particularly in 
men, remaining unexplained9. Although infertility has been related 
to advanced AFB, ovulation defects, failure of spermatogenesis, and 
single-gene or polygenic defects, the causal effects for these factors 
remain unsubstantiated10.
Recently, genetic and clinical research has focused on proximal 
infertility phenotypes3,4,10,11. AFB and NEB represent accurate meas-
ures of complex reproductive outcomes, are frequently recorded and 
consistently measured, and are key parameters for demographic 
population forecasting12. There is evidence of a genetic component 
underlying reproduction, with heritability estimates of up to 50% 
for AFB and NEB (Supplementary Fig. 1)6. A recent study attrib-
uted 15% of the variance in AFB and 10% of the variance in NEB to 
common genetic variants13. There are also sex-specific differences in 
human reproduction, related to the timing of fertility, fecundability 
and sex–genotype interactions (Supplementary Note). Researchers 
have given less attention to traits such as NEB because of an erroneous 
and frequently repeated misinterpretation of Fisher’s fundamental 
theorem of natural selection14 that the additive genetic variance in 
fitness should be close to zero. This misreading of the theorem had 
a naively intuitive appeal: genes that reduce fitness should be passed 
on less frequently. Fisher, however, actually argues that fitness is 
moderately heritable in human populations (for a discussion, see the 
Supplementary Note). As no established genes are currently avail-
able for clinical testing of infertility10, isolating genetic loci and their 
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We applied a single genomic control at the cohort level and 
performed meta-analysis of results using a sample-size-weighted 
fixed-effect method in METAL (Supplementary Note). The PLINK 
clumping function isolated ‘lead SNPs’—those with the lowest P value 
for association that are independently associated—using an r2 thresh-
old of 0.1 and a distance threshold of 500 kb. For AFB, we identified 
ten loci associated at genome-wide significance (P < 5 × 10−8 for 
combined results and P < 1.67 × 10−8 for sex-specific results adjusted 
for multiple testing), of which 9 were significantly associated in both 
sexes combined and 1 was associated in women only (n = 154,839) 
(Fig. 1a and Table 1). Three loci were significantly associated with 
NEB: two in both sexes combined and one in men only (n = 103,736) 
(Fig. 1b, Table 1 and Supplementary Note). One locus on chromo-
some 1 reached significance for association with both AFB and NEB 
with r2 = 0.57 between the two lead SNPs, suggesting a shared genetic 
basis for the two traits (Table 2). A statistical test of sex-specific effects 
confirmed that differences are mainly due to variation in sample size 
and not variation in effect size (Supplementary Note).
As for other complex traits18, the quantile–quantile plots of the 
meta-analyses exhibited strong inflation of low P values (Fig. 2), sug-
gesting that, although cohorts controlled for the top principal compo-
nents and cohort-level genomic control was applied (Supplementary 
Note), residual population stratification may remain. However, the 
LD Score intercept method19 as well as a series of individual and 
within-family regression analyses using polygenic scores as predic-
tors20,21 (Supplementary Note) indicated that the observed inflation 
was almost entirely attributable to a true polygenic signal, rather than 
population stratification.
Gene-based	GWAS
To increase the power to find statistically significant associations and 
causal genes, we additionally performed a gene-based GWAS using 
VEGAS22,23. The results confirmed top hits from the single-SNP 
analyses. For AFB, seven loci from the SNP-based GWAS were also 
represented in the gene-based analysis (Supplementary Table 3), and 
three additional loci emerged, represented by SLF2 (chromosome 10), 
ENO4 (chromosome 10) and TRAF3-AMN (chromosome 14). For 
NEB, one locus from the SNP-based GWAS was represented in the 
gene-based analysis—GATAD2B (chromosome 1)—and one new 
locus on chromosome 17 was identified (Supplementary Table 4).
Causal	variants
To identify functional and potentially causal variants, both coding and 
regulatory, within loci identified in the SNP-based GWAS (Table 1), 
we first performed an in silico sequencing annotation analysis using 
the post-GWAS pipeline reported by Vaez et al.24. This showed that 
rs10908557 on chromosome 1 is in high linkage disequilibrium 
(LD) with nonsynonymous SNPs in CRTC2 (rs11264680; r2 = 0.98) 
and CREB3L4 (rs11264743; r2 = 0.94) (Supplementary Table 5). 
Interestingly, rs11264743 is considered ‘deleterious’ and ‘probably 
damaging’ by SIFT and PolyPhen, respectively (Ensembl release 83). 
In addition, rs2777888 on chromosome 3 is in high LD with two 
nonsynonymous SNPs in MST1R (rs2230590, r2 = 0.95 and rs1062633, 
r2 = 0.95) (Table 1 and Supplementary Table 5).
We subsequently performed a comprehensive analysis using results 
from the Encyclopedia of DNA Elements (ENCODE)25 and Roadmap 
Epigenomics26 projects, as integrated in RegulomeDB27, to identify 
variants that likely influence downstream gene expression via regula-
tory pathways. Among all SNPs that reached P < 5 × 10−8 in the meta-
analyses (n = 322), 50 SNPs in five loci showed the most evidence of 
having functional consequences (Table 1 and Supplementary Table 6). ta
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Two sets of SNPs on chromosome 1 (18 SNPs) and chromosome 3 
(25 SNPs) stand out in particular. The most promising SNP in the 
chromosome 1 locus (rs6680140) is located in a site of acetylation of 
histone H3 at lysine 27 (H3K27ac), often found near active regula-
tory elements, and lies in a DNase I hypersensitivity cluster where 
eight proteins are anticipated to bind. One of these proteins is cAMP 
responsive element binding (CREB)-binding protein, encoded by 
CREBBP. In the chromosome 3 locus, rs2526397 is located in a 
transcription factor binding site and is an expression quantitative 
trait locus (eQTL) for HYAL3 in monocytes, while rs2247510 and 
rs1800688 are located in H3K27ac sites and DNase I hypersensitivity 
clusters where a large number of transcription factors are expected 
to bind (Supplementary Table 6). An analysis using Haploplotter 
showed that rs2247510 and rs7628058 in the chromosome 3 locus 
are among the 5% of signals showing the most evidence of positive 
selection in the population. The same applies to the lead SNP of the 
chromosome 14 locus for NEB (rs2415984).
Causal	genes
Information on the function and anticipated relevance of genes 
in the 12 loci identified in the SNP-based GWAS that are most 
likely to be causal on the basis of all evidence discussed below is 
provided in Table 2.
Cis-	and	trans-eQTL	and	meQTL	analyses
Identifying alterations in gene methylation status and/or expression 
levels in relation to GWAS-identified variants may help prioritize causal 
genes. We examined associations with gene expression and methylation 
status for the 12 independent lead SNPs in whole-blood BIOS eQTL 
(n = 2,116) and methylation quantitative trait locus (meQTL; n = 3,841) 
databases in cis and trans28,29. Seven SNPs were associated in cis with the 
expression of 54 unique genes (Table 1 and Supplementary Table 7). 
Five of these seven SNPs were in high LD (r2 > 0.8) with the strongest 
eQTL for at least one of the genes within the corresponding locus, 
indicating that the SNP associated with AFB or NEB and the SNP most 
significantly associated with expression tag the same functional site: 
rs10908557 (associated with the expression of CRTC2 and SLC39A1), 
rs1160544 (AFF3), rs2777888 (RBM6, RNF123 and RBM5), rs2721195 
(CYHR1, GPT, RECQL4 and PPP1R16A) and rs293566 (NOL4L). Three 
SNPs were associated with the expression of a total of eight genes in 
trans (Table 1 and Supplementary Table 8). Of these SNPs, only 
rs2777888 was in high LD (r2 > 0.8) with the strongest eQTL for three 
of its five associated genes: LRFN1, LAMP2 and FGD3.
The meQTL analysis showed that 11 of the 12 independent lead 
SNPs were associated with DNA methylation of a total of 131 unique 
genes in cis (Table 1 and Supplementary Table 9). Seven of the 11 
SNPs were in high LD (r2 > 0.8) with the strongest meQTL for one 
of the corresponding methylation sites: rs10908557 (associated with 
methylation of CRTC2, SLC39A1, CREB3L4, DENND4B and RAB13), 
rs1160544 (AFF3), rs2777888 (CAMKV), rs6885307 (C5orf34), 
rs10056247 (JADE2), rs2721195 (CYHR1) and rs13161115 (EFNA5). 
Three of the SNPs were associated with the same genes for both meth-
ylation and gene expression in cis: rs10908557 (CRTC2), rs1160544 
(AFF3) and rs2721195 (CYHR1) (Supplementary Tables 7 and 9). 
Three SNPs were associated with methylation of a total of ten genes 
in trans (Table 1 and Supplementary Table 10). Of these SNPs, only 
rs2777888 was in high LD (r2 > 0.8) with the strongest meQTL for 
a corresponding methylation site (ASAP3). Of note, rs2777888 was 
also a trans-eQTL.
Gene	prioritization
We used four publicly available bioinformatics tools to systematically 
identify genes that are more likely than neighboring genes to cause 
the associations identified by our GWAS. Of all genes that reached 
P < 0.05 in analyses using Endeavor30, MetaRanker31 and ToppGene32, 
eight genes were prioritized for both AFB and NEB: TPM3, GRM7, 
TKT, MAGI2, PTPRD, PTPRM, RORA and WT1. DEPICT—a fourth 
comprehensive and unbiased recently described gene prioritization 
tool33—identified three genes in GWAS significant loci as likely being 
causal for AFB (MON1A, RBM6 and U73166.2) (Supplementary 
Tables 11 and 12).
Gene-based	results	from	RegulomeDB
An analysis using RegulomeDB identified 50 SNPs in five loci that 
most likely have regulatory consequences (Supplementary Table 6). 
Eighteen and 25 of these SNPs are within the chromosome 1 and 
chromosome 3 loci, respectively. Among the genes that, at a protein 
level, bind at the site of one or more of the 18 variants in the locus on 
chromosome 1 are CREBBP, HNF4A, CDX2 and ERG. These genes 
may act upstream in the causal pathway and influence the expres-
sion of causal genes at this locus. Of the 25 SNPs on chromosome 
3, 10 were eQTLs for RBM6 in monocytes and 7 were eQTLs for 
HYAL3 in monocytes. Among the genes that, at a protein level, bind 
at rs2247510 and rs1800688 in the chromosome 3 locus are ARID3A, 
REST and TFAP2C, as well as HNF4A and CDX2, which also bind at 
the chromosome 1 locus.
Figure 1 Manhattan plots of SNPs for age at first birth and number of children ever born in single-genomic-control meta-analysis. (a,b) SNPs are plotted 
on the x axis according to their position on each chromosome against association with AFB (a) and NEB (b). The solid blue line indicates the threshold 
for genome-wide significance (P < 5 × 10−8), and the red line represents the threshold for suggestive hits (P < 5 × 10−6). Blue points represent SNPs in 
a 100- kb region centered on genome-wide significant hits. Loci are annotated with the names of the genes closest to the significant SNPs.
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table 2 Function and potential relevance for genes in GWAs-identified loci that are most likely causal on the basis of all available 
evidence
Lead SNP Gene Chr. Evidence Gene function and potential role in reproduction and (in)fertility Ref.
rs10908557 CRTC2 1 G, V, ctQ, ctM,  
Q lymph. (R)
Functions as a Ca2+- and cAMP-sensitive coincidence sensor; promotes CREB target gene  
expression; signal mediator in FSH and TGF-β1 steroidogenesis in ovarian granulosa cells
42
rs10908557 CREB3L4 1 N, V, cQ, cM Has a role in protein maturation; involved in spermatid differentiation and male germ cell  
development; expressed in prostate, oocytes, fallopian tube and mammary gland
44,45
rs10908557 GATAD2B 1 V, Q monoc. (R) Transcriptional repressor and a component of nucleosome remodeling complex Mi2/NuRD; 
increased expression in endometriosis; linked to a common gynecological disorder that causes 
pelvic pain and infertility
58,59
rs10908557 SLC39A1 1 V, cQ, cM Zinc uptake transporter; major zinc regulator in prostate cells; involved in the regulation of zinc 
homeostasis by cumulus cells in the oocyte
60,61
rs10908557 DENND4B 1 cM Paralog of DENN1A, which has been implicated in polycystic ovary syndrome; expressed at the 
protein level in the cervix
46,62
rs1160544 AFF3 2 cQ, cM Lymphoid nuclear transcriptional activator implicated in tumorigenesis; same family as AFF3 
and AFF4 (FMR2 family member 4); transcriptional regulator in testicular somatic cells;  
essential for male germ cell differentiation and survival in mice
63,64
rs1160544 LINC01104 2 G, V Unknown
rs2777888 HYAL3 3 cM, Q monoc. (R) Hyaluronidases, including HYAL3, are involved in degradation of hyaluronan, a major  
glycosaminoglycan of the extracellular matrix; acquired during sperm maturation in the  
epididymis and involved in sperm function and the acrosome reaction; required for in vitro 
cumulus penetration in mice, although its absence is not associated with infertility (perhaps 
compensated for by other hyaluronidases)
65
rs2777888 RBM6 3 V, cQ, cM, DEPICT,  
Q monoc. (R)
Involved in RNA splicing 66
rs2777888 RNF123 3 V, cQ, cM,  
Q liver (R)
Has a role in cellular transitioning from quiescence to a proliferative state through its E3 
ubiquitin ligase activity toward cyclin-dependent kinase inhibitor 1B, which controls cell cycle 
progression in G1 phase
66–68
rs2777888 RBM5 3 V, cQ Involved in cell cycle regulation; regulator of pre-mRNA splicing; involved in spermatogenesis 
and fertility in mice
47
rs2777888 MON1A 3 V, cM, DEPICT Involved in the movement and trafficking of proteins (for example, ferroportin) through the  
secretory apparatus
69
rs2777888 U73166.2 3 DEPICT Unknown
rs2777888 MST1R 3 N, V, cM,  
MetaRanker,  
ToppGene and 
Endeavor
Cell surface receptor for MSP with tyrosine kinase activity, expressed on ciliated epithelia  
of the mucociliary transport apparatus of the lung; involved in host defense, expressed in sperm; 
may act in a regulatory system of ciliary motility, together with MSP, which sweeps eggs along 
the oviduct; expressed in mucous membrane and mammary gland
70
rs10056247 JADE2 5 G, V, cM Involved in histone acetylation
rs13161115 EFNA5 5 cM Involved in development and differentiation of the nervous system and folliculogenesis  
regulation; required for normal fertility in female mice; expressed in embryonic stem cells  
and embryoid bodies
50
rs6885307 HCN1 5 G, cM Hyperpolarization-activated cation channel that contributes to the native pacemaker current  
in, for example, neurons; HCN1 channels are present in kisspeptin (Kiss1) neurons in the  
rostral periventricular area of the third ventricle (RP3V), which provide an excitatory drive to 
gonadotropin-releasing hormone (GnRH)-expressing neurons that control fertility
71
rs2347867 ESR1 6 G, cM, binds  
at rs4851269  
on chr. 2 (R)
Transcription factor involved in estrogen-responsive gene expression; essential for sexual  
development and reproductive function in women; genetic variants in ESR1 may influence  
susceptibility to endometriosis or female fertility in patients with endometriosis; involved  
in male fertility by transferring estrogen effect; expressed in myometrium, endometrium, oocytes, 
uterus and fallopian tube
51,52, 
72–74
rs10953766 FOXP2 7 G, cM, binds  
at rs6997  
on chr. 3 (R)
Transcription factor expressed in fetal and adult brain that is involved in speech and language 
development; involved in regulation of neuronal development in the embryonic forebrain;  
expressed in mucous membrane and myometrium
75
rs2721195 CYHR1 8 cQ, cM Histidine-cysteine-rich protein involved in spermatogenesis 53
rs2721195 GPT 8 V, cQ, cM, Q monoc. 
(R)
Involved in intermediary metabolism of glucose and amino acids; may have a role in  
spermatogenesis via testicular glucose metabolism, which is pivotal for the normal occurrence  
of spermatogenesis; levels in the normal range are positively associated with metabolic and  
endocrine abnormalities in women of reproductive age and negatively associated with FSH 
levels, independent of obesity
76,77
rs2721195 RECQL4 8 V, cQ, cM Processing of aberrant DNA structures that arise during DNA replication and repair;  
predominantly expressed in testis
78
rs2721195 PPP1R16A 8 V, cQ, cM, Q monoc. 
(R)
Regulator of protein phosphatase PP1β; present in the sperm tail where it interacts with  
proteins that are important in sperm structure and motility; expressed in mammary gland  
and fallopian tube
79
rs293566 NOL4L 20 cQ, cM Component of cytoplasm and nucleoplasm; expressed in umbilical vein
Evidence categories include the nearest gene (G), nonsynonymous variants (N), gene-based GWAS performed in VEGAS (V), eQTLs in cis and/or trans (ctQ), meQTLs in cis and/or 
trans (ctM), eQTLs (Q) in lymphoblasts (lymph), monocytes (monoc) or liver based on RegulomeDB (R), gene prioritization using either DEPICT or MetaRanker, ToppGene and  
Endeavor, and protein binding at SNPs based on RegulomeDB (R). Chr., human chromosome on which the gene is located; FSH, follicle-stimulating hormone; CREB, cAMP  
response element–binding protein; TGF-β1, transforming growth factor β1; MSP, macrophage-stimulating protein. SNIPPER was used for the literature search, with the search 
terms “fertility,” “sperm,” “ovum” and “reproduction.”
Gene Network was used to find the tissue or organ with high expression for a given gene (AUC > 0.8).
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Five genes encode proteins that bind at the site of both SNPs on 
chromosome 2 that reach P < 5 × 10−8 in the meta-analysis of GWAS. 
One of these is REST; another one, ESR1, is the most likely causal gene 
in the chromosome 6 locus.
Functional	network	and	enrichment	analyses
Functional network analysis using five prioritized candidate gene sets 
as input (Supplementary Note) showed no significantly enriched 
biological function. No biological function was significantly enriched 
after correction for multiple testing using the Benjamini–Hochberg 
procedure. Similarly, no reconstituted gene sets and cell or tissue types 
were significantly enriched in the GWAS meta-analysis results based 
on results from the DEPICT analysis (Supplementary Tables 13–20). 
The lack of significantly enriched genes, tissue sets and biological 
functions reflects the need for a larger sample size but also the distal 
nature of the phenotypes, which are influenced by a mixture of bio-
logical, psychological and socioenvironmental factors.
Polygenic	prediction
To assess the predictive power of our results, we produced polygenic 
scores for AFB and NEB with sets of SNPs whose nominal P values 
ranged from P < 5 × 10−8 (using only genome-wide significant SNPs) 
to 1 (using all SNPs that passed quality control) using PRSice34 
(Supplementary Note). We then performed a series of four differ-
ent out-of-sample predictions in four independent cohorts: HRS, 
LifeLines, STR and TwinsUK. Across the four cohorts, the mean pre-
dictive power of a polygenic score constructed from all measured SNPs 
is 0.9% for AFB and 0.2% for NEB (Supplementary Fig. 2). Despite the 
low predictive power of the polygenic scores, the results showed that 
an increase of 1 s.d. in the NEB polygenic score is associated with a 9% 
(95% confidence interval (CI) = 5–13%) decrease in the probability 
of women remaining childless, with no significant association 
in men (Supplementary Table 21). When we controlled for right- 
censored data using a survival model for AFB, we found that an increase 
of 1 s.d. in the AFB polygenic score was associated with an 8% (95% 
CI = 7–10%) reduction in the hazard ratio of reproduction in women 
and a 3% (95% CI = 1–5%) reduction in men (Supplementary Table 22). 
As an additional test, we examined whether the aforementioned poly-
genic scores for AFB and NEB could predict related fertility traits such 
as age at menopause and age at menarche (Supplementary Table 23). 
Our estimates indicated that an increase of 1 s.d. in the AFB polygenic 
score was associated with a 3% decrease in the probability of natural 
menopause at any age (95% CI = 1–5%) and a 20-d increase in age at 
menarche (95% CI = 0.4–40 d).
Genetic	association	with	related	traits	and	diseases
Several loci for which the associations with AFB and NEB reached 
genome-wide significance are associated with behavioral and repro-
ductive phenotypes. The lead SNPs in the chromosome 2 and chromo-
some 3 loci have been associated with educational attainment35 and 
the locus on chromosome 5 has been associated with age at menarche2, 
while the locus on chromosome 6 has recently been associated with age 
at first sexual intercourse11 (Supplementary Table 24). Some of the 38 
loci for age at first sexual intercourse that were recently identified11 
in 125,667 UK Biobank participants were also associated with AFB 
(in or near RBM6–SEMA3F and ESR1) and NEB (in or near CADM2 
and ESR1). The lead SNPs for RBM6–SEMA3F (rs2188151) and ESR1 
(rs67229052) are in LD with our lead SNPs for AFB on chromosome 3 
(r2 = 0.44) and chromosome 6 (r2 = 0.94), respectively. An in silico 
pleiotropy analysis showed that our lead SNP in the chromosome 3 
locus (rs2777888) is in LD (r2 = 0.59) with rs6762477, which has been 
associated with age at menarche2, while other SNPs in the same locus 
have been associated with HDL cholesterol36 (rs2013208, r2 = 0.81) 
and body mass index (BMI)37 (rs7613875, r2 = 0.81) (Supplementary 
Table 5). We next performed an exploratory analysis using the proxy 
phenotype method38 to examine whether the SNPs strongly associ-
ated with AFB in women are empirically plausible candidate SNPs 
for related traits such as age at menarche and age at menopause 
(Supplementary Note). After controlling for multiple testing, we 
identified three AFB-associated SNPs near rs2777888 on chromosome 
3 (rs9589, rs6803222 and rs9858889) that are also associated with age 
at menarche (P < 4.10 × 10−4). None of the AFB- or NEB-associated 
SNPs are associated with age at menopause.
We performed a bivariate LD score regression analysis39 to esti-
mate the pairwise genetic correlation with 27 publicly available 
GWAS results for traits associated with human reproductive behavior 
(Supplementary Note). AFB showed significant and positive genetic 
correlation with the human (reproductive) developmental traits of 
age at menarche, voice breaking, age at menopause, birth weight 
and age at first sexual intercourse, as well as with years of education. 
Conversely, having more AFB-increasing alleles was associated with 
a lower genetic risk of smoking (ever, number of cigarettes and later 
onset) and with lower insulin-resistance-related phenotypes, that is, 
BMI, waist–hip ratio adjusted for BMI, fasting insulin, triglyceride 
levels and risk of diabetes (Fig. 3 and Supplementary Table 25). 
All genetic correlations remained significant after Bonferroni cor-
rection for multiple testing (P < 2.6 × 10−3). Years of education 
(P = 6.6 × 10−14) and age at first sexual intercourse (P = 1.14 × 10−15) 
are the only traits that showed significant and negative genetic corre-
lation with NEB. We also observed significant genetic correlations of 
rg = 0.86 (standard error (SE) = 0.052) for AFB and rg = 0.97 (SE = 0.095) 
for NEB between men and women, implying that most genetic 
effects on reproductive behavior resulting from common SNPs are 
shared by both sexes.
DISCUSSION
This GWAS is a large-scale genetic epidemiological discovery effort 
for human reproduction, with implications for population fitness and 
physiological mechanisms linking hypothesized genes and observed 
phenotypes. Related studies previously focused on reproductive 
life span40,41, age at first sexual intercourse11 and more proximal 
infertility phenotypes2–4, largely overlooking AFB and NEB. The 
rapid postponement of AFB and increased infertility and involuntary 
childlessness in many societies7 make it important to uncover the 
genetic and biological architecture of reproduction. We identify ten 
Figure 2 Quantile–quantile plots. (a,b) SNPs for AFB (a) and NEB (b) 
in single-genomic-control meta-analysis. The gray-shaded areas in the 
quantile–quantile plots represent the 95% confidence bands around  
the P values under the null hypothesis.
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new and confirm two recently identified genetic loci that are robustly 
associated with AFB and NEB, as well as variants and genes within 
these loci that potentially drive these associations. Four additional 
loci were identified in a gene-based GWAS.
Two loci that show interesting results in follow-up analyses are 
located on chromosomes 1 and 3. The lead SNPs of the chromosome 
1 locus for AFB and NEB are in LD with likely functional nonsyn-
onymous SNPs in genes encoding (i) CREB-regulated transcription 
co-activator 2 (CRTC2), which at the protein level acts as a critical 
signal mediator in follicle-stimulating hormone (FSH) and transform-
ing growth factor (TGF)-β1–stimulated steroidogenesis in ovarian 
granulosa cells42; and (ii) CREB protein 3 like 4 (CREB3L4)43, which 
in humans is highly expressed in the prostate, ovaries, uterus, placenta 
and testis and has a role in spermatid differentiation44 and male germ 
cell development45. The lead SNP and/or functional variants in LD 
with it are also associated with the methylation status of these two 
genes and expression of CRTC2 in whole blood and lymphocytes. 
Three promising functional variants in the chromosome 1 locus reside 
in binding sites of the transcriptional co-activator CREBBP. In addition 
to a direct effect of the above-mentioned nonsynonymous SNPs on 
protein function, the associations of AFB and NEB with variants in the 
locus on chromosome 1 may thus be mediated by alterations in cAMP 
responsive element binding in men and women. The locus on chromo-
some 1 also harbors DENND4B, a paralog of DENND1A, implicated in 
polycistic ovary syndrome (PCOS)46. Whereas DENND1A is expressed 
at the protein level in the ovary and testis, DENND4B is expressed in 
the cervix and its function and role are less well understood.
The lead SNP of the locus on chromosome 3 (rs2777888) is associated 
with methylation and expression of several genes, in cis and trans, that 
are known to have a role in cell cycle progression and/or sperm function. 
First, rs2777888 is associated with the expression of RNF123 (or KPC1) 
in cis, which has a role in cellular transition from quiescence to a 
proliferative state. Second, rs2777888 or functional variants in LD 
with it may influence the cell cycle by altering the expression of RBM5 
and RBM6 (RNA-binding motif proteins 5 and 6). The former has a 
role in cell cycle arrest and apoptosis induction and regulates haploid 
male germ cell pre-mRNA splicing and fertility in mice. Rmb5-mutant 
mice exhibit spermatid differentiation arrest, germ cell sloughing and 
apoptosis, leading to lack of sperm in ejaculation47. Third, rs2777888 
affects expression of LAMP2 in trans, which is located on the X 
chromosome and encodes a lysosomal membrane protein involved in 
the acrosome reaction, that is, the enzymatic drill allowing sperm to 
penetrate and fertilize ova48. LAMP2 is expressed at the protein level in 
male and female reproductive organs with an effect size of rs2777888 
for LAMP2 mRNA expression that is almost twice as large in women 
than it is in men (Supplementary Fig. 3). This suggests an impor-
tant role for the lysosome in both sperm and ova. Finally, functional 
variants in the chromosome 3 locus are associated with the mRNA 
expression of HYAL3 (hyaluronoglucosaminidase 3) in monocytes. 
The encoded protein degrades hyaluronan, which also has an impor-
tant role in sperm function and the acrosome reaction47,49.
Functional follow-up experiments could disentangle the potential 
interplay between many candidate genes in the loci on chromosomes 
1 and 3 in reproductive behavior and, given our in silico results, infer-
tility. This can be extended to candidate genes in the remaining loci 
identified in the present study, some of which are relevant for fertility: 
mice lacking Efna5 (chromosome 5 NEB locus) are subfertile50, ESR1 
on chromosome 6 encodes an estrogen receptor51,52 and CYHR1 on 
chromosome 8 is involved in spermatogenesis53. Such experiments 
would help in understanding whether binding of estrogen receptor 1, 
*
*
Waist−hip ratio
BMI
Height
Fasting insulin level
Diabetes
Triglycerides
LDL cholesterol
Autism
Alzheimer’s disease
Subjective well-being
Bipolar
Schizophrenia
Openness
Neuroticism
Age onset of smoking
Ever smoked
Cigarettes per day
Years of education
Birth weight
Birth length
Dizygotic twinning
Age at first sexual intercourse
PCOS
Voice breaking
Tanner stage male and female combined
Age at menopause
Age at menarche
–0.5 0.0 0.5 1.0
Genetic correlation
P
he
no
ty
pe
s
Fertility traits
Number of children ever born
Age at first birth
Genetic overlap between fertility traits and other phenotypes
*
*
* *
*
* *
*
*
*
*
*
*
*
*
*
Figure 3 Genetic overlap between AFB or NEB and other related traits. Results from LD Score regressions show estimates of genetic correlation with 
developmental, reproductive, behavioral, neuropsychiatric and anthropometric phenotypes for which GWAS summary statistics were available in the 
public domain. The lengths of the bars correspond to estimates of genetic correlation. Gray error bars represent 95% confidence intervals. An asterisk 
indicates that the estimate of genetic correlation is statistically significant after controlling for multiple testing (P < 0.05/27 = 1.85 × 10−3).
1468	 VOLUME 48 | NUMBER 12 | DECEMBER 2016 Nature GeNetics
A rt i c l e s
encoded by ESR1 in the locus on chromosome 6, at the site of func-
tional variants in the locus on chromosome 2 drives or mediates the 
association with AFB in the chromosome 2 locus, as well as to identify 
and characterize causal genes. Recent developments in high-through-
put, multiplex mutagenesis using CRISPR/Cas9 allow such experi-
ments to be performed using in vivo model systems54.
AFB and NEB are not only driven by biological processes, but are 
also subject to individual choice and personal characteristics such 
as personality traits, as well as by the historical, cultural, economic 
and social environment (for example, effective contraception and 
childcare availability). Demographic research has shown a strong 
positive association between AFB and educational attainment12. We 
show that the associations between fecundity, reproductive behavior 
and educational attainment are partly driven by genetic factors and 
identified loci that are associated with AFB as well as with, for exam-
ple, age at first sexual intercourse11 and educational attainment35.
Our findings could lead to insights into how postponing reproduc-
tion may be more detrimental for some, on the basis of their genetic 
make-up, than others, fuel experiments to determine ‘how late can 
you wait’ (ref. 55) and stimulate reproductive awareness. Causal genes 
in the loci we identified could potentially serve as novel drug targets, 
to prevent or delay age-related declines in fertility and sperm quality 
or to increase assisted reproductive technology efficiency, but further 
characterization is needed. Our study examines the genetics of repro-
ductive behavior in both men and women, and, to our knowledge, it 
is the first that is adequately powered to identify loci in both women 
and men. We also provide support for Fisher’s theorem that fitness 
is moderately heritable in human populations. Although the effect 
sizes of the identified common variants are small, there are examples 
of GWAS-identified loci of small effect that end up leading to impor-
tant biological insights56,57. Many of our findings suggest a role for 
sperm quality, which is one lead for researchers to pursue. Because 
current sperm tests remain rudimentary, our findings could serve as 
a basis for ‘good quality’ sperm markers. We identified both coding 
and regulatory variants that are potentially causal, as well as a set of 
genes that could underlie the associations we identified. Follow-up 
experiments in animal models are required to confirm and character-
ize the causal genes in these loci.
URLs. Analysis plan predeposited at the Open Science Framework 
website, https://osf.io/53tea/; Gene Network, http://129.125.135.18
0:8080/GeneNetwork/; ReproGen, http://www.reprogen.org/data_
download.html; Sociogenome, http://www.sociogenome.com/; Social 
Science Genetic Association Consortium, http://thessgac.org/.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE	METHODS
GWAS of reproductive behavior study design in brief. Genome-wide asso-
ciation analyses of AFB and NEB were performed at the cohort level accord-
ing to a prespecified analysis plan (Supplementary Note). Cohort-uploaded 
results were imputed using the HapMap 2 CEU (r22.b36) or 1000 Genomes 
Project reference sample. Cohorts were asked to only include participants of 
European ancestry, with no missing values for all relevant covariates (sex, birth 
year and cohort-specific covariates), who were successfully genotyped 
over the whole genome and passed cohort-specific quality control filters. 
We followed the quality control protocol of the GIANT Consortium’s recent 
study of human height20 and employed QCGWAS16 and EasyQC17 software, 
which allowed us to harmonize the files and identify possible sources of error 
in association results.
Cohort association results (after applying the quality control filters) were 
combined using sample-size-weighted meta-analysis with genomic control 
correction within each study, implemented in METAL80. SNPs were considered 
genome-wide significant at P values smaller than 5 × 10−8 (α = 5%, Bonferroni 
corrected for 1 million tests). The meta-analyses were carried out by two inde-
pendent analysts. Detailed results for each genome-wide significant locus are 
shown in in Supplementary Figures 4–29.
The total sample size of the meta-analyses is n = 251,151 for AFB pooled 
and n = 343,072 for NEB pooled. The PLINK clumping function81 was used 
to identify the most significant SNPs in associated regions (termed lead 
SNPs). Detailed cohort descriptions, information about cohort-level geno-
typing and imputation procedures, cohort-level measures and quality control 
filters are shown in Supplementary Tables 26 and 27 and discussed in the 
Supplementary Note.
Dominant genetic variation in fertility. We applied a method recently devel-
oped by Zhu et al.82 to estimate dominant genetic effects on the basis of the 
genetic relatedness of unrelated individuals. Our results, based on combined 
TwinsUK and LifeLines samples, showed no evidence of dominant genetic 
effects for either NEB (1.0 × 10−7, SE = 0.07; P = 0.45) or AFB (0.02, SE = 0.08; 
P = 0.43). Results are shown in Supplementary Table 28 and discussed in the 
Supplementary Note.
Bivariate and conditional analyses. As joint analysis of correlated traits may 
boost power for mapping functional loci, we applied a recently developed mul-
tiple-trait analysis method83 to test the association between each variant and 
the two correlated traits AFB and NEB simultaneously using multivariate anal-
ysis of variance (MANOVA) (Supplementary Table 29 and Supplementary 
Note). The analysis was performed on the basis of the genome-wide meta-
analysis summary statistics for each single trait. Although this analysis did not 
identify additional genome-wide significant loci (λ = 0.995), it did account for 
the correlation between the two phenotypes, thus improving the strength of 
two signals on chromosomes 1 and 5, indicating possible pleiotropic architec-
ture for AFB and NEB (Supplementary Fig. 30). The analysis also provided 
a conditional association test of the genetic effect of each variant on AFB 
including NEB as a covariate and the genetic effect on NEB including AFB as 
a covariate (Supplementary Fig. 31).
Population stratification. We used two methods to assess whether our GWAS 
results exhibited signs of population stratification (Supplementary Note). 
First, we used the LD Score intercept method described in Bulik-Sullivan et al.19 
to test whether inflation in χ2 statistics was due to confounding biases such as 
cryptic relatedness and population stratification. In all six cases, the intercept 
estimates were not significantly different from 1, suggesting no appreciable 
inflation of the test statistics attributable to population stratification. Second, 
we conducted a series of individual and within-family regressions using poly-
genic scores as predictors20,21,38 on a data set of dizygotic twins (STR and 
TwinsUK). The regression analyses showed that within-family regression 
coefficients for both AFB and NEB were statistically different from 0 when 
the P-value threshold was sufficiently high (Supplementary Figs. 32 and 33, 
and Supplementary Tables 30 and 31).
Sex-specific effects. In addition to the pooled GWAS for which results are 
presented in the main text, we also ran sex-specific GWAS meta-analyses 
for AFB and NEB (Supplementary Note). The sample sizes for sex-specific 
analysis were as follows: AFB in women, n = 189,656; AFB in men, n = 48,408; 
NEB in women, n = 225,230; NEB in men, n = 103,909. Our results identified 
six genome-wide significant (P < 5 × 10−8) independent SNPs for AFB in 
women and one genome-wide significant independent SNP for NEB in men 
(Supplementary Figs. 34 and 35, and Supplementary Table 32). We also 
used LD Score bivariate regression and GREML bivariate analysis to estimate 
the genetic correlation between men and women on the basis of the sex-specific 
summary statistics from the AFB and NEB meta-analyses. Our estimates 
based on LD bivariate regression indicated genetic correlations between the 
sexes of rg = 0.86 (SE = 0.052) for AFB and rg = 0.97 (SE = 0.095) for NEB. 
Results are shown in Supplementary Tables 33 and 34 and discussed in the 
Supplementary Note.
Polygenic score prediction. We performed out-of-sample prediction and cal-
culated polygenic scores for AFB and NEB, on the basis of genome-wide asso-
ciation meta-analysis results, and used regression models to predict the same 
phenotypes in four independent cohorts: HRS, LifeLines, STR and TwinsUK 
(Supplementary Fig. 2 and Supplementary Note). We ran ordinary least-
squares (OLS) regression models and report R2 as a measure of goodness of 
fit for the model. In addition, we tested how well our polygenic scores for NEB 
could predict childlessness at the end of the reproductive period (using age 45 
for women and 55 for men; Supplementary Table 21). Because AFB is observed 
only in parous women, we adopted an additional statistical model to account 
for censoring (Cox proportional hazard model; Supplementary Table 22) 
and selection (Heckman selection model; Supplementary Table 35). We addi-
tionally tested the predictive value of our polygenic scores for AFB on age 
at menarche (TwinsUK) and age at menopause (LifeLines) (Supplementary 
Table 23). Finally, we examined whether variants associated with menopause 
are associated with AFB. We calculated a polygenic score for age at menopause 
based on recent GWAS results from Day et al.40 and applied the predictor to 
the LifeLines and TwinsUK cohorts (Supplementary Table 36).
Genetic correlations. We used information from 27 publicly available GWAS 
data sets to estimate the number of genetic correlations between AFB or NEB 
and related traits (Fig. 3 and Supplementary Table 25) via LD Score bivariate 
regression. Details on these phenotypes are provided in the Supplementary 
Note. A conservative Bonferroni-corrected P-value threshold of P < 1.85 × 10−3 
(= 0.05/27) was used to define significant associations. We also tested the 
correlation between NEB and AFB using bivariate GREML analysis on the 
Women’s General Health Study (WGHS; n = 40,621).
Lookups and proxy phenotypes. Following up on the results of genetic 
overlap with other phenotypes, we tested in a quasi-phenotype replication 
setting whether the SNPs strongly associated with AFB in women were empiri-
cally plausible candidate SNPs for age at menarche and age at menopause 
(Supplementary Note). We used a two-stage approach applied in other con-
texts38,84. In the first stage, we conducted a meta-analysis of AFB excluding 
cohorts that were part of the meta-analysis for the phenotype we intended to 
replicate. We merged the SNPs from this meta-analysis with the publically 
available association results for the most recent GWAS on age at menarche2 
and age at menopause40 from the ReproGen consortium website1. SNPs that 
were not present in both studies considered were dropped from the analysis. 
We aligned alleles and directions of effect using EasyStrata software85. We then 
selected independent SNPs with P < 1 × 10−5, using the clump procedure in 
PLINK81 (window size of 1,000 kb and LD threshold of r2 > 0.1) to identify 
the most significant SNPs in the associated regions included in both files. 
We defined ‘prioritized SNP associations’ as those that passed the Bonferroni 
correction for the number of SNPs tested (0.05/122 = 4.10 × 10−4, for both 
age at menarche and age at menopause). Our results identified three SNPs 
after Bonferroni correction that could be used as good candidates for age at 
menarche. We did not find any clear ‘candidate SNP’ for age at menopause 
(Supplementary Fig. 36).
Gene-based GWAS analysis. We performed gene-based testing with the 
full GWAS set (~2.5 million HapMap-imputed SNPs) for both phenotypes 
using VEGAS (Supplementary Tables 3 and 4, and Supplementary Note)22,23. 
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This software has the advantage of accounting for LD structure and allowing 
a gene to be defined as a range with boundaries beyond the edges of the gene 
to include intergenic regions in the analysis. We defined genes including an 
additional 50-kb window around each gene. We considered every SNP for the 
gene-based analysis, ran the analyses for each chromosome with up to 106 
permutations and considered P < 2.5 × 10−6 as the threshold for significance 
(0.05/~20.000 genes).
eQTL and meQTL analyses. For each of the 12 SNPs identified in the GWAS, 
local (cis; exons or methylation sites <1 Mb from the SNP) and genome-wide 
(trans; exons or methylation sites >5 Mb from the SNP) effects were identified 
by computing Spearman rank correlations between SNPs and local or global 
exons and methylation sites (Supplementary Note). Bonferroni correction 
for multiple testing was performed for the 12 SNPs tested (P < 2.5 × 10−6 for 
cis-meQTL analysis, P < 1 × 10−8 for trans-meQTL analysis, P < 1.2 × 10−6 
for cis-eQTL analysis, P < 1.3 × 10−8 for trans-eQTL analysis). For each of the 
significant associations, the corresponding exons or methylation sites were 
selected, the strongest eQTLs were identified for these elements and the LD 
between the strongest eQTLs and the corresponding SNP identified in the 
GWAS was computed. LD was computed using BIOS genotypes (genotypes 
used for eQTL and meQTL mapping).
Functional variant analysis using RegulomeDB. We used RegulomeDB27 to 
identify variants among the 322 SNPs that reached P < 5 × 10−8 for associa-
tion with AFB and/or NEB in the meta-analysis of GWAS results that likely 
influence regulation of gene expression (Supplementary Note). RegulomeDB 
integrates results from the Roadmap Epigenomics26 and ENCODE86 projects. 
SNPs showing the most evidence of being functional—defined by having a 
RegulomeDB score <4—were subsequently examined in more detail in terms 
of effects on gene expression (eQTLs) and their protein-binding capacity 
(Supplementary Table 6).
Gene prioritization. Potentially causal genes for the associations identified 
by GWAS were identified using four previously described bioinformat-
ics tools: ToppGene4, Endeavor5, MetaRanker6 and DEPICT7. To this end, 
we first retrieved positional coordinates for all lead SNPs according to 
GRCh37/hg19 using Ensembl BioMart. These coordinates were used to extract 
all genes located within 40 kb of lead SNPs from the UCSC table browser. 
The identified genes then served as input for ToppGene and Endeavor. 
Genes with established roles in fertility served as training genes in this 
procedure, that is, BRCA1, EGFR, ERBB2, ERBB3, ERBB4, HSD17B1, RBM5, 
ESR1, ESR2 and FSHB. For MetaRanker, we provided SNPs that reached 
P < 5 × 10−4 and their chromosomal positions as input, together with the 
above set of training genes. Because ToppGene, Endeavor and MetaRanker 
are biased toward larger and well-described genes, we also performed a gene 
prioritization procedure using DEPICT7. All SNPs that reached P < 5 × 10−4 
in the meta-analysis served as input, and information on prioritized genes, 
gene set enrichment, and tissue and cell type enrichment was extracted. Genes 
were subsequently prioritized if they (i) reached P < 0.05 in DEPICT or (ii) 
reached P < 0.05 in ToppGene, Endeavor and MetaRanker (Supplementary 
Table 37).
Functional network and enrichment analyses. DEPICT was used to identify 
gene set, cell type and tissue enrichment, using the GWAS-identified SNPs 
with P < 5 × 10−4 as input (Supplementary Note). Because of the relatively 
small number of identified loci, DEPICT was only able to perform these analy-
ses for AFB and NEB pooled and for AFB in women. To construct a functional 
association network, we combined five prioritized candidate gene sets into 
a single query gene set that was then used as input for functional network 
analysis24. We applied the GeneMANIA algorithm together with its large set of 
accompanying functional association data87. We used the Cytoscape software 
platform88, extended by the GeneMANIA plugin (data version 8/12/2014, 
accessed 24 April 2016)89. All the genes in the composite network, from either 
the query or resulting gene sets, were then used for functional enrichment 
analysis against Gene Ontology (GO) terms90 to identify the most relevant 
terms, using the same plugin89.
Gene–environment interactions. Previous research based on twin studies 
shows differential heritability of fertility behavior across birth cohorts91,92. 
We used the Swedish Twin Register (STR) to examine whether the effect of a 
polygenic score for AFB or NEB varied across birth cohort. We followed the 
analysis presented in the recent GWAS of education35 and divided the sample 
into six groups on the basis of year of birth. Each group spanned five birth 
years, with the oldest ranging from 1929–1933 and the youngest born from 
1954–1958. Supplementary Table 38 reports the estimated coefficients from 
these regressions. The results indicate a U-shaped trend in AFB and a linear 
decline in NEB, but they do not provide any clear evidence of interaction 
effects between the polygenic scores and birth cohort. We additionally tested 
the interaction effects for educational level and the polygenic scores for AFB 
and NEB in three different samples (LifeLines, STR and HRS). Supplementary 
Table 39 reports the estimated coefficients from these regressions. The results 
indicate that years of education are positively associated with AFB in both the 
LifeLines and STR cohorts and negatively associated with NEB in the HRS 
cohort. With the exception of NEB in the HRS cohort, we found no evidence 
of gene–environment effects with education.
Robustness checks. To estimate the robustness of our results for AFB, we 
conducted two additional analyses. First, we estimated how the coeffi-
cients changed if we controlled for educational attainment. Using data from 
deCODE, we ran an additional association analysis using the ten loci that were 
genome-wide significant in the meta-analysis (P < 5 × 10−8). The analysis 
was restricted to individuals born between 1910 and 1975 who also had data 
available on completed education. The total sample size was 42,187 (17,996 
males and 24,191 females). The analysis was adjusted for sex, year of birth 
(linear, squared and cubed), interaction between sex and year of birth, and 
the first ten principal components. Education is measured by years of educa-
tion, ranging between 10 and 20 years. Supplementary Table 40 reports the 
association results before and after adjusting for educational attainment. Our 
analysis shows that effect sizes shrink after including educational attainment 
as a covariate, with an average reduction of around 15%. We also estimated 
the effect of a polygenic risk score for AFB calculated from meta-analysis data 
excluding the deCODE cohort. The polygenic risk score remained highly sig-
nificant. The effect of 1 s.d. for the AFB score decreased from 0.19 years (69 d) 
without controlling for education to 0.16 years (59 d) when we controlled for 
years of education. Second, we estimated how the coefficients changed after 
controlling for educational attainment and age at first sexual intercourse using 
the UK Biobank cohort (n = 50,954). We ran two association models: the first 
followed the GWAS analysis plan with no additional covariates, and the second 
added years of education and age at first sexual intercourse as covariates. 
The results are presented in Supplementary Figure 37 and Supplementary 
Table 41. Our analysis shows that the effect sizes of our top hits are highly 
concordant (R2 = 0.94). The inclusion of educational attainment and age at first 
sexual intercourse as covariates weakened the effect sizes on average by 40% 
and increased the P values of the estimated coefficients. Overall, we interpret 
this additional analysis as a robustness test that confirms that the top hits from 
our meta-analysis are robust to the inclusion of the confounding factors of 
educational attainment and age at first sexual intercourse.
Positive selection. We performed Haploplotter analysis93 to examine whether 
lead SNPs and/or functional variants identified using RegulomeDB showed 
evidence of positive selection. Three variants showed standardized integrated 
haplotype scores <–2 or >2, indicating that these variants represent the top 5% 
of signals in the population. These SNPs are (i) rs7628058 on chromosome 3 for 
AFB, an eQTL for RBM6 in monocytes; (ii) rs2247510 on chromosome 3 for 
AFB, an eQTL for RBM6 and HYAL3 in monocytes and a binding site for a 
range of transcription factors; and (iii) rs2415984, the lead SNP in the chromo-
some 14 locus for NEB. Results are presented in Supplementary Table 42.
Data availability. Results can be downloaded from the SOCIOGENOME and 
SSGAC website. Data come from multiple studies, most of which are subject 
to a MTA, and are listed in the Supplementary Note. Correspondence and 
requests for materials should be addressed to the corresponding authors or 
info@sociogenome.com.
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